New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareProstamax vs Vialox

Prostamax vs Vialox

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Prostamax
Skin & CosmeticAnti-Aging & Longevity
Vialox
Summary
Prostamax is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) developed by Professor Vladimir Khavinson, tissue-specific for the prostate gland. It supports prostate epithelial cell function, promotes normalization of prostate tissue, and is studied for its potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate anti-aging. It is one of the more widely used Khavinson bioregulators among men over 40.
Vialox is a synthetic pentapeptide that mimics the activity of conotoxin from cone snails, acting as an antagonist of nicotinic acetylcholine receptors at the neuromuscular junction. Similar to Syn-Ake but derived from cone snail venom biochemistry, it reduces facial muscle contraction to smooth expression wrinkles.
Half-Life
Short (minutes); sustained gene-regulatory effects
Not applicable (topical; effect duration hours)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
0.005-0.05% in formulation
Frequency
Daily for 10–30 days
Twice daily
Key Benefits
  • Supports normalization of prostate tissue architecture
  • May reduce prostate enlargement associated with BPH
  • Anti-inflammatory effects on prostatic tissue
  • Reduces prostate cell apoptosis from oxidative stress
  • Potential support in chronic prostatitis
  • Anti-aging effects on prostate glandular tissue
  • Complementary to conventional BPH therapies
  • Reduces dynamic wrinkles from repetitive facial expressions
  • Reversible muscle-relaxing effect without injection
  • Smooths forehead, periorbital, and perioral lines
  • Complementary to collagen-stimulating peptides
  • Well-studied tolerability in cosmetic concentrations
  • Can be combined with Syn-Ake for dual conotoxin/viper venom effect
Side Effects
  • Generally well tolerated in available research
  • Mild injection site reactions
  • No significant adverse urological events reported at standard doses
  • Generally very well-tolerated topically
  • Rare contact sensitivity or mild irritation
  • No clinically significant systemic neuromuscular effects at cosmetic doses
Stacks With